Are you Dr. Penas-Prado?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 12 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Marta Penas-Prado, MD is a neurologist in Houston, Texas. She is currently licensed to practice medicine in Texas. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
University of Santiago de CompostelaClass of 1998
Certifications & Licensure
TX State Medical License 2014 - 2024
Clinical Trials
- Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Start of enrollment: 2005 Sep 01
- Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) Start of enrollment: 2007 Nov 28
- Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma Start of enrollment: 2011 Jul 12
- Join now to see all
Publications & Presentations
PubMed
- Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.James L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, Lisa Boris, Yeonju Kim, Kenneth Aldape, Martha M Quezado, John A Butman, James G Smirniotopoulos, Huma Chaudhry,...> ;Journal of Neuro-Oncology. 2024 Mar 1
- Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings.Briceno, N., Vera, E., Komlodi-Pasztor, E., Abdullaev, Z., Choi, A., Grajkowska, E., Kunst, T., Levine, J., Lindsley, M., Fernandez, K., Reyes, J., Boris, L., Burton, ...> ;Neuro-Oncology Advances. 2024 Feb 8
- Clinical impact of molecular profiling in rare brain tumors.Drew Pratt, Marta Penas-Prado, Mark R Gilbert> ;Current Opinion in Neurology. 2023 Dec 1
- Join now to see all
Press Mentions
Experimental Medulloblastoma Treatment Gets a Boost with NanoparticlesFebruary 25th, 2022
NCI-CONNECT and BTTC 2019 MeetingsJune 3rd, 2019
How Pleomorphic Xanthoastrocytoma Brought Us TogetherJuly 17th, 2018- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
